| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 10 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-12-09 |
4 |
AS |
$199.94 |
$3,332,000 |
D/D |
(16,665) |
943,676 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-12-17 |
4 |
AS |
$177.67 |
$2,966,315 |
D/D |
(16,680) |
943,676 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-12-17 |
4 |
OE |
$22.90 |
$381,972 |
D/D |
16,680 |
960,356 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-12-18 |
4 |
AS |
$182.03 |
$2,500,182 |
D/D |
(13,735) |
929,941 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-02-03 |
4 |
S |
$174.25 |
$522,750 |
D/D |
(3,000) |
926,941 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-02-04 |
4 |
S |
$172.44 |
$387,583 |
D/D |
(2,223) |
924,718 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
33,990 |
958,708 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-02-09 |
4 |
S |
$173.98 |
$1,506,667 |
D/D |
(8,660) |
950,048 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-02-10 |
4 |
S |
$171.15 |
$982,401 |
D/D |
(5,740) |
944,308 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
22,300 |
966,608 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-03-02 |
4 |
S |
$180.34 |
$221,818 |
D/D |
(1,230) |
965,378 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-03-19 |
4 |
AS |
$188.07 |
$3,000,093 |
D/D |
(15,952) |
949,426 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
950,126 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-06-18 |
4 |
AS |
$179.63 |
$5,000,001 |
D/D |
(27,835) |
922,291 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-08-04 |
4 |
S |
$196.52 |
$432,344 |
D/D |
(2,200) |
920,091 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-08-07 |
4 |
S |
$190.01 |
$190,580 |
D/D |
(1,003) |
919,088 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-09-09 |
4 |
AS |
$180.10 |
$189,105 |
D/D |
(1,050) |
919,088 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-11-02 |
4 |
AS |
$180.12 |
$6,304,200 |
D/D |
(35,000) |
919,088 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-11-02 |
4 |
A |
$22.90 |
$801,500 |
D/D |
35,000 |
954,088 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-11-25 |
4 |
OE |
$22.90 |
$801,500 |
D/D |
35,000 |
954,088 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-11-25 |
4 |
AS |
$180.29 |
$6,366,288 |
D/D |
(35,000) |
919,088 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-12-08 |
4 |
AS |
$185.30 |
$13,173,840 |
D/D |
(70,000) |
849,088 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-12-11 |
4 |
S |
$187.41 |
$3,998,527 |
I/I |
(21,319) |
727,940 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
99,829 |
749,259 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-12-17 |
4 |
OE |
$22.90 |
$1,603,000 |
D/D |
70,000 |
819,259 |
0 |
- |
|
283 Records found
|
|
Page 10 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
